

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 6.04280928 |
| 2 | neuron cell-cell adhesion (GO:0007158) | 5.74174606 |
| 3 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.56415593 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.41486088 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.28858299 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.20271453 |
| 7 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.13420747 |
| 8 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.10967538 |
| 9 | protein localization to synapse (GO:0035418) | 5.07846311 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.02750211 |
| 11 | presynaptic membrane assembly (GO:0097105) | 4.98094805 |
| 12 | glutamate secretion (GO:0014047) | 4.95022286 |
| 13 | glutamate receptor signaling pathway (GO:0007215) | 4.88568802 |
| 14 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.80115403 |
| 15 | behavioral response to nicotine (GO:0035095) | 4.74147196 |
| 16 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.72589474 |
| 17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.64514222 |
| 18 | neuronal action potential propagation (GO:0019227) | 4.63584723 |
| 19 | presynaptic membrane organization (GO:0097090) | 4.59273958 |
| 20 | locomotory exploration behavior (GO:0035641) | 4.56730344 |
| 21 | synaptic transmission, glutamatergic (GO:0035249) | 4.54307084 |
| 22 | neuron-neuron synaptic transmission (GO:0007270) | 4.53522222 |
| 23 | postsynaptic membrane organization (GO:0001941) | 4.46544331 |
| 24 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.40460215 |
| 25 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.39765222 |
| 26 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.34164053 |
| 27 | exploration behavior (GO:0035640) | 4.18715212 |
| 28 | regulation of synaptic vesicle transport (GO:1902803) | 4.18606755 |
| 29 | neurotransmitter secretion (GO:0007269) | 4.16121028 |
| 30 | synaptic vesicle maturation (GO:0016188) | 4.11343489 |
| 31 | positive regulation of synapse maturation (GO:0090129) | 4.09693753 |
| 32 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.00150454 |
| 33 | neuron recognition (GO:0008038) | 3.96071919 |
| 34 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.95431241 |
| 35 | response to histamine (GO:0034776) | 3.94491994 |
| 36 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.93684013 |
| 37 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.89370104 |
| 38 | long-term synaptic potentiation (GO:0060291) | 3.86190474 |
| 39 | cerebellar granule cell differentiation (GO:0021707) | 3.82176207 |
| 40 | regulation of postsynaptic membrane potential (GO:0060078) | 3.79815450 |
| 41 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.76532971 |
| 42 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.76290899 |
| 43 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.73242117 |
| 44 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.72890908 |
| 45 | startle response (GO:0001964) | 3.70594581 |
| 46 | long-term memory (GO:0007616) | 3.65836637 |
| 47 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.63677803 |
| 48 | gamma-aminobutyric acid transport (GO:0015812) | 3.59921258 |
| 49 | serotonin metabolic process (GO:0042428) | 3.57012963 |
| 50 | axonal fasciculation (GO:0007413) | 3.53641250 |
| 51 | positive regulation of membrane potential (GO:0045838) | 3.53258527 |
| 52 | regulation of synaptic plasticity (GO:0048167) | 3.46985110 |
| 53 | regulation of synapse maturation (GO:0090128) | 3.46928902 |
| 54 | neurotransmitter transport (GO:0006836) | 3.45553658 |
| 55 | transmission of nerve impulse (GO:0019226) | 3.45313869 |
| 56 | positive regulation of synapse assembly (GO:0051965) | 3.41899195 |
| 57 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.39433046 |
| 58 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.39077770 |
| 59 | synapse assembly (GO:0007416) | 3.35218379 |
| 60 | regulation of synapse structural plasticity (GO:0051823) | 3.35215515 |
| 61 | behavioral fear response (GO:0001662) | 3.34458376 |
| 62 | behavioral defense response (GO:0002209) | 3.34458376 |
| 63 | proline transport (GO:0015824) | 3.33634819 |
| 64 | regulation of neurotransmitter secretion (GO:0046928) | 3.32469042 |
| 65 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.32400669 |
| 66 | primary amino compound metabolic process (GO:1901160) | 3.28494711 |
| 67 | auditory behavior (GO:0031223) | 3.25782747 |
| 68 | regulation of glutamate secretion (GO:0014048) | 3.25707778 |
| 69 | synaptic vesicle endocytosis (GO:0048488) | 3.24856060 |
| 70 | mechanosensory behavior (GO:0007638) | 3.24041322 |
| 71 | membrane depolarization (GO:0051899) | 3.23725619 |
| 72 | fear response (GO:0042596) | 3.21655264 |
| 73 | positive regulation of neurotransmitter transport (GO:0051590) | 3.18873013 |
| 74 | regulation of neurotransmitter levels (GO:0001505) | 3.18456263 |
| 75 | negative regulation of response to food (GO:0032096) | 3.17361258 |
| 76 | negative regulation of appetite (GO:0032099) | 3.17361258 |
| 77 | learning (GO:0007612) | 3.16448744 |
| 78 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.16318579 |
| 79 | neuronal action potential (GO:0019228) | 3.15993003 |
| 80 | dendritic spine morphogenesis (GO:0060997) | 3.15624411 |
| 81 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.13097630 |
| 82 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.12423183 |
| 83 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.12020361 |
| 84 | protein polyglutamylation (GO:0018095) | 3.09885338 |
| 85 | nucleobase catabolic process (GO:0046113) | 3.09738613 |
| 86 | innervation (GO:0060384) | 3.09592503 |
| 87 | synaptic transmission (GO:0007268) | 3.09187438 |
| 88 | regulation of neurotransmitter uptake (GO:0051580) | 3.09074712 |
| 89 | regulation of vesicle fusion (GO:0031338) | 3.08994303 |
| 90 | cell proliferation in forebrain (GO:0021846) | 3.07651899 |
| 91 | behavioral response to cocaine (GO:0048148) | 3.07148562 |
| 92 | positive regulation of synaptic transmission (GO:0050806) | 3.06785742 |
| 93 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.05934748 |
| 94 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.05313728 |
| 95 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.05313728 |
| 96 | regulation of membrane repolarization (GO:0060306) | 3.04484736 |
| 97 | regulation of neurotransmitter transport (GO:0051588) | 3.04348265 |
| 98 | layer formation in cerebral cortex (GO:0021819) | 3.03717581 |
| 99 | membrane hyperpolarization (GO:0060081) | 3.03053166 |
| 100 | membrane depolarization during action potential (GO:0086010) | 3.01964832 |
| 101 | response to auditory stimulus (GO:0010996) | 3.01062114 |
| 102 | short-term memory (GO:0007614) | 3.00911675 |
| 103 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.00555836 |
| 104 | cochlea development (GO:0090102) | 2.99629191 |
| 105 | regulation of synaptic transmission (GO:0050804) | 2.98543507 |
| 106 | regulation of synapse assembly (GO:0051963) | 2.97467441 |
| 107 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.97407380 |
| 108 | detection of calcium ion (GO:0005513) | 2.96709640 |
| 109 | negative regulation of neurotransmitter transport (GO:0051589) | 2.94967470 |
| 110 | response to amphetamine (GO:0001975) | 2.94939311 |
| 111 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.93771606 |
| 112 | cellular potassium ion homeostasis (GO:0030007) | 2.93449584 |
| 113 | somite development (GO:0061053) | 2.91971719 |
| 114 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.91011165 |
| 115 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.91011165 |
| 116 | long term synaptic depression (GO:0060292) | 2.90338810 |
| 117 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.89466035 |
| 118 | activation of protein kinase A activity (GO:0034199) | 2.88793787 |
| 119 | negative regulation of dendrite development (GO:2000171) | 2.88647847 |
| 120 | regulation of action potential (GO:0098900) | 2.87524319 |
| 121 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.84708857 |
| 122 | neurofilament cytoskeleton organization (GO:0060052) | 2.81105618 |
| 123 | action potential (GO:0001508) | 2.80488295 |
| 124 | sulfation (GO:0051923) | 2.79896270 |
| 125 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.79817251 |
| 126 | dopamine transport (GO:0015872) | 2.78774009 |
| 127 | multicellular organismal signaling (GO:0035637) | 2.76384419 |
| 128 | behavioral response to ethanol (GO:0048149) | 2.75675843 |
| 129 | adaptation of signaling pathway (GO:0023058) | 2.73840774 |
| 130 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.70975147 |
| 131 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.63943552 |
| 132 | NADH dehydrogenase complex assembly (GO:0010257) | 2.63943552 |
| 133 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.63943552 |
| 134 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.62909697 |
| 135 | neuromuscular synaptic transmission (GO:0007274) | 2.61747128 |
| 136 | positive regulation of amino acid transport (GO:0051957) | 2.59617145 |
| 137 | regulation of dopamine secretion (GO:0014059) | 2.58275380 |
| 138 | regulation of response to food (GO:0032095) | 2.56256528 |
| 139 | adult walking behavior (GO:0007628) | 2.55608209 |
| 140 | neuromuscular process controlling posture (GO:0050884) | 2.54251085 |
| 141 | regulation of female receptivity (GO:0045924) | 2.53972421 |
| 142 | adult behavior (GO:0030534) | 2.53589614 |
| 143 | cAMP catabolic process (GO:0006198) | 2.52313444 |
| 144 | potassium ion import (GO:0010107) | 2.51386967 |
| 145 | membrane repolarization during action potential (GO:0086011) | 2.51127915 |
| 146 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.50922010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.82990377 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.49129741 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.09803666 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.00346647 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.98310098 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.72762786 |
| 7 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.60278541 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.51334143 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.51334143 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.49454252 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48473876 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.47456577 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.44232753 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.42262377 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.39716873 |
| 16 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.32513348 |
| 17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.30995334 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.26953493 |
| 19 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.25595270 |
| 20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.22425171 |
| 21 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.16253137 |
| 22 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.99951275 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.97854643 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.96456761 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.96161438 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.94545576 |
| 27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.93871981 |
| 28 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.93457958 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.93330719 |
| 30 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.93246671 |
| 31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.93109742 |
| 32 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.92582489 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.91624259 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90524544 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.87548287 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.86856297 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.85722376 |
| 38 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.84242524 |
| 39 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.75511778 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.73162961 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.72840625 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.70214238 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.62507794 |
| 44 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.60012471 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.57399182 |
| 46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.55295938 |
| 47 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.54267909 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.53179287 |
| 49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.51418008 |
| 50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.50179638 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.49231848 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45903736 |
| 53 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.45612659 |
| 54 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44395799 |
| 55 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.43511722 |
| 56 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41867672 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.40058981 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38908144 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.36428359 |
| 60 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35864483 |
| 61 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32382571 |
| 62 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.31772852 |
| 63 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.29378541 |
| 64 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.26825374 |
| 65 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.26356500 |
| 66 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25266302 |
| 67 | TCF4_23295773_ChIP-Seq_U87_Human | 1.24913683 |
| 68 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.22610001 |
| 69 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.19964530 |
| 70 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19271336 |
| 71 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18855790 |
| 72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18081709 |
| 73 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.17597912 |
| 74 | JUN_21703547_ChIP-Seq_K562_Human | 1.16977641 |
| 75 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.16914809 |
| 76 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.16656740 |
| 77 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.16656740 |
| 78 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16394563 |
| 79 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.16310940 |
| 80 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14512277 |
| 81 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11529436 |
| 82 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09927782 |
| 83 | AR_19668381_ChIP-Seq_PC3_Human | 1.09500416 |
| 84 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08958193 |
| 85 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08841353 |
| 86 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08841353 |
| 87 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08129922 |
| 88 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.07464524 |
| 89 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.06858165 |
| 90 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.05214736 |
| 91 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04912771 |
| 92 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.04704048 |
| 93 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04655814 |
| 94 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04453900 |
| 95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04093823 |
| 96 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03197893 |
| 97 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02750135 |
| 98 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02342360 |
| 99 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01984845 |
| 100 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01322313 |
| 101 | EWS_26573619_Chip-Seq_HEK293_Human | 1.01198363 |
| 102 | KDM2B_26808549_Chip-Seq_REH_Human | 1.00883705 |
| 103 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00794305 |
| 104 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99887532 |
| 105 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99717769 |
| 106 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.99264567 |
| 107 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98920110 |
| 108 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98882464 |
| 109 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98471001 |
| 110 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.98024947 |
| 111 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.97595757 |
| 112 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96819075 |
| 113 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96583555 |
| 114 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.96400299 |
| 115 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.96018539 |
| 116 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95716090 |
| 117 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95672117 |
| 118 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93632514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.58811494 |
| 2 | MP0003880_abnormal_central_pattern | 5.57785590 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.02328150 |
| 4 | MP0009745_abnormal_behavioral_response | 3.53790396 |
| 5 | MP0004270_analgesia | 3.34806336 |
| 6 | MP0009046_muscle_twitch | 3.32932839 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.29642913 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.24916018 |
| 9 | MP0002064_seizures | 3.22852557 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.95506719 |
| 11 | MP0002736_abnormal_nociception_after | 2.89119838 |
| 12 | MP0002272_abnormal_nervous_system | 2.71271881 |
| 13 | MP0002735_abnormal_chemical_nociception | 2.69758564 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.56850326 |
| 15 | MP0001486_abnormal_startle_reflex | 2.54707882 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.53012796 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.43703278 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.26867318 |
| 19 | MP0002067_abnormal_sensory_capabilities | 2.22737529 |
| 20 | MP0001188_hyperpigmentation | 2.18603842 |
| 21 | MP0006276_abnormal_autonomic_nervous | 2.11328740 |
| 22 | MP0002822_catalepsy | 2.03927000 |
| 23 | MP0002733_abnormal_thermal_nociception | 1.97108915 |
| 24 | MP0002184_abnormal_innervation | 1.96132054 |
| 25 | MP0001529_abnormal_vocalization | 1.93292106 |
| 26 | MP0005646_abnormal_pituitary_gland | 1.91864680 |
| 27 | MP0001970_abnormal_pain_threshold | 1.90363660 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 1.90082377 |
| 29 | MP0000778_abnormal_nervous_system | 1.89181680 |
| 30 | MP0003787_abnormal_imprinting | 1.81397379 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.81175751 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.79908681 |
| 33 | MP0004924_abnormal_behavior | 1.79908681 |
| 34 | MP0003879_abnormal_hair_cell | 1.77346503 |
| 35 | MP0001984_abnormal_olfaction | 1.71195383 |
| 36 | MP0008569_lethality_at_weaning | 1.58511651 |
| 37 | MP0003122_maternal_imprinting | 1.56082509 |
| 38 | MP0001905_abnormal_dopamine_level | 1.52029054 |
| 39 | MP0003646_muscle_fatigue | 1.50154669 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.47774818 |
| 41 | MP0004811_abnormal_neuron_physiology | 1.47213461 |
| 42 | MP0006072_abnormal_retinal_apoptosis | 1.46475303 |
| 43 | MP0004142_abnormal_muscle_tone | 1.44590174 |
| 44 | MP0003329_amyloid_beta_deposits | 1.44021624 |
| 45 | MP0004133_heterotaxia | 1.42333961 |
| 46 | MP0002066_abnormal_motor_capabilities/c | 1.38449073 |
| 47 | MP0000955_abnormal_spinal_cord | 1.38136986 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.34836879 |
| 49 | MP0000049_abnormal_middle_ear | 1.34239065 |
| 50 | MP0002837_dystrophic_cardiac_calcinosis | 1.32399385 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.32374128 |
| 52 | MP0004858_abnormal_nervous_system | 1.30678267 |
| 53 | MP0002876_abnormal_thyroid_physiology | 1.27387773 |
| 54 | MP0001502_abnormal_circadian_rhythm | 1.27061975 |
| 55 | MP0003283_abnormal_digestive_organ | 1.25728424 |
| 56 | MP0004742_abnormal_vestibular_system | 1.21458714 |
| 57 | MP0002909_abnormal_adrenal_gland | 1.19869240 |
| 58 | MP0005253_abnormal_eye_physiology | 1.13339244 |
| 59 | MP0003633_abnormal_nervous_system | 1.12780430 |
| 60 | MP0003011_delayed_dark_adaptation | 1.12152500 |
| 61 | MP0003938_abnormal_ear_development | 1.08439100 |
| 62 | MP0004130_abnormal_muscle_cell | 1.08394456 |
| 63 | MP0010386_abnormal_urinary_bladder | 1.07723058 |
| 64 | MP0005171_absent_coat_pigmentation | 1.06283935 |
| 65 | MP0002160_abnormal_reproductive_system | 1.03803245 |
| 66 | MP0004885_abnormal_endolymph | 1.03257827 |
| 67 | MP0004145_abnormal_muscle_electrophysio | 1.01897666 |
| 68 | MP0004147_increased_porphyrin_level | 1.01768613 |
| 69 | MP0009379_abnormal_foot_pigmentation | 1.00926840 |
| 70 | MP0002152_abnormal_brain_morphology | 1.00706028 |
| 71 | MP0003631_nervous_system_phenotype | 0.99815851 |
| 72 | MP0005084_abnormal_gallbladder_morpholo | 0.99060862 |
| 73 | MP0001963_abnormal_hearing_physiology | 0.98729608 |
| 74 | MP0005409_darkened_coat_color | 0.97206807 |
| 75 | MP0002928_abnormal_bile_duct | 0.93624907 |
| 76 | MP0003119_abnormal_digestive_system | 0.93552475 |
| 77 | MP0008872_abnormal_physiological_respon | 0.91833031 |
| 78 | MP0005551_abnormal_eye_electrophysiolog | 0.91036205 |
| 79 | MP0004484_altered_response_of | 0.91032778 |
| 80 | MP0000751_myopathy | 0.90578843 |
| 81 | MP0004085_abnormal_heartbeat | 0.89530856 |
| 82 | MP0002229_neurodegeneration | 0.88037584 |
| 83 | MP0002234_abnormal_pharynx_morphology | 0.87621132 |
| 84 | MP0004215_abnormal_myocardial_fiber | 0.87358873 |
| 85 | MP0005195_abnormal_posterior_eye | 0.87181472 |
| 86 | MP0002069_abnormal_eating/drinking_beha | 0.85587956 |
| 87 | MP0008874_decreased_physiological_sensi | 0.82868608 |
| 88 | MP0000631_abnormal_neuroendocrine_gland | 0.82849593 |
| 89 | MP0005389_reproductive_system_phenotype | 0.81364797 |
| 90 | MP0003136_yellow_coat_color | 0.80866145 |
| 91 | MP0009250_abnormal_appendicular_skeleto | 0.77979421 |
| 92 | MP0002752_abnormal_somatic_nervous | 0.77065301 |
| 93 | MP0001485_abnormal_pinna_reflex | 0.76431723 |
| 94 | MP0005499_abnormal_olfactory_system | 0.76360952 |
| 95 | MP0005394_taste/olfaction_phenotype | 0.76360952 |
| 96 | MP0000013_abnormal_adipose_tissue | 0.75844917 |
| 97 | MP0001293_anophthalmia | 0.75665373 |
| 98 | MP0001664_abnormal_digestion | 0.75353495 |
| 99 | MP0005535_abnormal_body_temperature | 0.73963866 |
| 100 | MP0001986_abnormal_taste_sensitivity | 0.73428625 |
| 101 | MP0002653_abnormal_ependyma_morphology | 0.70712254 |
| 102 | MP0000230_abnormal_systemic_arterial | 0.70323253 |
| 103 | MP0005167_abnormal_blood-brain_barrier | 0.70179231 |
| 104 | MP0003121_genomic_imprinting | 0.69912033 |
| 105 | MP0000026_abnormal_inner_ear | 0.69221325 |
| 106 | MP0003937_abnormal_limbs/digits/tail_de | 0.67920939 |
| 107 | MP0003632_abnormal_nervous_system | 0.66675226 |
| 108 | MP0001177_atelectasis | 0.66078497 |
| 109 | MP0003634_abnormal_glial_cell | 0.64956909 |
| 110 | MP0004043_abnormal_pH_regulation | 0.63876098 |
| 111 | MP0004134_abnormal_chest_morphology | 0.62305385 |
| 112 | MP0002102_abnormal_ear_morphology | 0.62126150 |
| 113 | MP0003183_abnormal_peptide_metabolism | 0.60842348 |
| 114 | MP0003137_abnormal_impulse_conducting | 0.59403390 |
| 115 | MP0002638_abnormal_pupillary_reflex | 0.57448950 |
| 116 | MP0001943_abnormal_respiration | 0.57432740 |
| 117 | MP0006292_abnormal_olfactory_placode | 0.54871231 |
| 118 | MP0003123_paternal_imprinting | 0.53894114 |
| 119 | MP0008877_abnormal_DNA_methylation | 0.53721482 |
| 120 | MP0000604_amyloidosis | 0.53687017 |
| 121 | MP0000015_abnormal_ear_pigmentation | 0.53037525 |
| 122 | MP0002082_postnatal_lethality | 0.52098720 |
| 123 | MP0010770_preweaning_lethality | 0.52098720 |
| 124 | MP0010769_abnormal_survival | 0.49775216 |
| 125 | MP0000920_abnormal_myelination | 0.48852820 |
| 126 | MP0003861_abnormal_nervous_system | 0.47275444 |
| 127 | MP0004233_abnormal_muscle_weight | 0.47121921 |
| 128 | MP0010768_mortality/aging | 0.46952105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.57167077 |
| 2 | Epileptic encephalopathy (HP:0200134) | 5.97320881 |
| 3 | Focal seizures (HP:0007359) | 5.87935579 |
| 4 | Atonic seizures (HP:0010819) | 5.85393598 |
| 5 | Hyperventilation (HP:0002883) | 5.49396753 |
| 6 | Febrile seizures (HP:0002373) | 5.38987892 |
| 7 | Myokymia (HP:0002411) | 5.31580456 |
| 8 | Absence seizures (HP:0002121) | 4.61956994 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.38148127 |
| 10 | Dialeptic seizures (HP:0011146) | 4.31893053 |
| 11 | Visual hallucinations (HP:0002367) | 4.24655117 |
| 12 | Broad-based gait (HP:0002136) | 4.24577864 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.96377898 |
| 14 | Gaze-evoked nystagmus (HP:0000640) | 3.37972630 |
| 15 | Poor eye contact (HP:0000817) | 3.25680580 |
| 16 | Drooling (HP:0002307) | 3.24443138 |
| 17 | Excessive salivation (HP:0003781) | 3.24443138 |
| 18 | Congenital stationary night blindness (HP:0007642) | 3.11872196 |
| 19 | Amblyopia (HP:0000646) | 3.11530854 |
| 20 | Protruding tongue (HP:0010808) | 3.03179441 |
| 21 | Pancreatic cysts (HP:0001737) | 3.02541823 |
| 22 | Nephronophthisis (HP:0000090) | 3.00034284 |
| 23 | True hermaphroditism (HP:0010459) | 2.98286063 |
| 24 | Absent speech (HP:0001344) | 2.96308474 |
| 25 | Abnormal social behavior (HP:0012433) | 2.93698056 |
| 26 | Impaired social interactions (HP:0000735) | 2.93698056 |
| 27 | Epileptiform EEG discharges (HP:0011182) | 2.92822233 |
| 28 | Progressive inability to walk (HP:0002505) | 2.91091597 |
| 29 | Pheochromocytoma (HP:0002666) | 2.91009958 |
| 30 | Pancreatic fibrosis (HP:0100732) | 2.88497837 |
| 31 | Inability to walk (HP:0002540) | 2.87787057 |
| 32 | Molar tooth sign on MRI (HP:0002419) | 2.87761308 |
| 33 | Abnormality of midbrain morphology (HP:0002418) | 2.87761308 |
| 34 | Fetal akinesia sequence (HP:0001989) | 2.85009610 |
| 35 | Truncal ataxia (HP:0002078) | 2.84152968 |
| 36 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.83279702 |
| 37 | Dysdiadochokinesis (HP:0002075) | 2.82570255 |
| 38 | Limb dystonia (HP:0002451) | 2.80129417 |
| 39 | Action tremor (HP:0002345) | 2.79973566 |
| 40 | Abnormality of binocular vision (HP:0011514) | 2.78586038 |
| 41 | Diplopia (HP:0000651) | 2.78586038 |
| 42 | Abnormal eating behavior (HP:0100738) | 2.77735397 |
| 43 | Abolished electroretinogram (ERG) (HP:0000550) | 2.74037235 |
| 44 | Neuroendocrine neoplasm (HP:0100634) | 2.67474348 |
| 45 | Anxiety (HP:0000739) | 2.67445638 |
| 46 | Stenosis of the external auditory canal (HP:0000402) | 2.66624517 |
| 47 | EEG with generalized epileptiform discharges (HP:0011198) | 2.61929974 |
| 48 | Dysmetria (HP:0001310) | 2.60624528 |
| 49 | Polyphagia (HP:0002591) | 2.60373697 |
| 50 | Blue irides (HP:0000635) | 2.60009422 |
| 51 | Hemiplegia (HP:0002301) | 2.58757355 |
| 52 | Abnormal hair whorl (HP:0010721) | 2.58397646 |
| 53 | Type II lissencephaly (HP:0007260) | 2.57404547 |
| 54 | Gait imbalance (HP:0002141) | 2.50342596 |
| 55 | Pendular nystagmus (HP:0012043) | 2.47313392 |
| 56 | Supranuclear gaze palsy (HP:0000605) | 2.45517324 |
| 57 | Scanning speech (HP:0002168) | 2.44520167 |
| 58 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.44263434 |
| 59 | Depression (HP:0000716) | 2.43390844 |
| 60 | Abnormality of the renal medulla (HP:0100957) | 2.41060756 |
| 61 | Hypsarrhythmia (HP:0002521) | 2.39076389 |
| 62 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.35854072 |
| 63 | Genetic anticipation (HP:0003743) | 2.33441881 |
| 64 | Impaired smooth pursuit (HP:0007772) | 2.32254685 |
| 65 | Abnormality of the renal collecting system (HP:0004742) | 2.30709156 |
| 66 | Fair hair (HP:0002286) | 2.27270225 |
| 67 | Abnormality of the corticospinal tract (HP:0002492) | 2.27094376 |
| 68 | Abnormality of salivation (HP:0100755) | 2.23762624 |
| 69 | Megalencephaly (HP:0001355) | 2.23293673 |
| 70 | Termporal pattern (HP:0011008) | 2.23232336 |
| 71 | Insidious onset (HP:0003587) | 2.23232336 |
| 72 | Hemiparesis (HP:0001269) | 2.20845627 |
| 73 | Congenital, generalized hypertrichosis (HP:0004540) | 2.17926310 |
| 74 | Morphological abnormality of the middle ear (HP:0008609) | 2.16505760 |
| 75 | Optic nerve hypoplasia (HP:0000609) | 2.15537132 |
| 76 | Generalized hypopigmentation of hair (HP:0011358) | 2.15316726 |
| 77 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.14808891 |
| 78 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.14410969 |
| 79 | Hyperthyroidism (HP:0000836) | 2.13845446 |
| 80 | Bradykinesia (HP:0002067) | 2.12812382 |
| 81 | Medial flaring of the eyebrow (HP:0010747) | 2.12702235 |
| 82 | Septo-optic dysplasia (HP:0100842) | 2.11399199 |
| 83 | Decreased circulating renin level (HP:0003351) | 2.11193022 |
| 84 | Dysmetric saccades (HP:0000641) | 2.11107793 |
| 85 | Status epilepticus (HP:0002133) | 2.10860437 |
| 86 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.10056030 |
| 87 | Congenital primary aphakia (HP:0007707) | 2.09635658 |
| 88 | Cerebral inclusion bodies (HP:0100314) | 2.09614735 |
| 89 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.09240065 |
| 90 | Mutism (HP:0002300) | 2.09041994 |
| 91 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.09008343 |
| 92 | Stereotypic behavior (HP:0000733) | 2.07791504 |
| 93 | Urinary urgency (HP:0000012) | 2.07394056 |
| 94 | Abnormality of the renal cortex (HP:0011035) | 2.06635240 |
| 95 | Ankle clonus (HP:0011448) | 2.06371151 |
| 96 | Postural instability (HP:0002172) | 2.04025468 |
| 97 | Failure to thrive in infancy (HP:0001531) | 2.03511647 |
| 98 | Nephrogenic diabetes insipidus (HP:0009806) | 2.02681437 |
| 99 | Generalized myoclonic seizures (HP:0002123) | 2.02219055 |
| 100 | Poor suck (HP:0002033) | 2.01429608 |
| 101 | Acute necrotizing encephalopathy (HP:0006965) | 2.00161894 |
| 102 | Impaired vibratory sensation (HP:0002495) | 1.98896879 |
| 103 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.98175390 |
| 104 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.98131588 |
| 105 | Decreased central vision (HP:0007663) | 1.97106104 |
| 106 | Thickened helices (HP:0000391) | 1.96717516 |
| 107 | Short tibia (HP:0005736) | 1.96627812 |
| 108 | Genital tract atresia (HP:0001827) | 1.96489507 |
| 109 | Vaginal atresia (HP:0000148) | 1.96473077 |
| 110 | Spastic gait (HP:0002064) | 1.95060467 |
| 111 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.94986647 |
| 112 | Dyskinesia (HP:0100660) | 1.93001972 |
| 113 | Specific learning disability (HP:0001328) | 1.92721629 |
| 114 | Widely spaced teeth (HP:0000687) | 1.92210603 |
| 115 | Progressive macrocephaly (HP:0004481) | 1.91494625 |
| 116 | Incomplete penetrance (HP:0003829) | 1.91422058 |
| 117 | Increased corneal curvature (HP:0100692) | 1.91100015 |
| 118 | Keratoconus (HP:0000563) | 1.91100015 |
| 119 | Lissencephaly (HP:0001339) | 1.90279449 |
| 120 | Synostosis involving the elbow (HP:0003938) | 1.89789516 |
| 121 | Humeroradial synostosis (HP:0003041) | 1.89789516 |
| 122 | Esotropia (HP:0000565) | 1.89278201 |
| 123 | Gait ataxia (HP:0002066) | 1.89241948 |
| 124 | Akinesia (HP:0002304) | 1.88962572 |
| 125 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.88493043 |
| 126 | Absent/shortened dynein arms (HP:0200106) | 1.88493043 |
| 127 | Inappropriate behavior (HP:0000719) | 1.87429529 |
| 128 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.87377229 |
| 129 | Pachygyria (HP:0001302) | 1.86951288 |
| 130 | Exotropia (HP:0000577) | 1.86644908 |
| 131 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.86066009 |
| 132 | Short hallux (HP:0010109) | 1.85813877 |
| 133 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.85364307 |
| 134 | Torticollis (HP:0000473) | 1.84959958 |
| 135 | Gastroesophageal reflux (HP:0002020) | 1.84798936 |
| 136 | Neurofibrillary tangles (HP:0002185) | 1.84748910 |
| 137 | Myotonia (HP:0002486) | 1.83203234 |
| 138 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.82769818 |
| 139 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.82065593 |
| 140 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.82065593 |
| 141 | Agitation (HP:0000713) | 1.80718183 |
| 142 | Abnormality of the lower motor neuron (HP:0002366) | 1.80632036 |
| 143 | Abnormality of the labia minora (HP:0012880) | 1.79856256 |
| 144 | Cystic liver disease (HP:0006706) | 1.79761348 |
| 145 | Abnormality of cochlea (HP:0000375) | 1.78863218 |
| 146 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.76359963 |
| 147 | Focal dystonia (HP:0004373) | 1.75797777 |
| 148 | Lower limb muscle weakness (HP:0007340) | 1.75520140 |
| 149 | Sclerocornea (HP:0000647) | 1.75214041 |
| 150 | Psychosis (HP:0000709) | 1.75093180 |
| 151 | Asplenia (HP:0001746) | 1.73530172 |
| 152 | Abnormal drinking behavior (HP:0030082) | 1.73316288 |
| 153 | Polydipsia (HP:0001959) | 1.73316288 |
| 154 | Methylmalonic acidemia (HP:0002912) | 1.73182194 |
| 155 | Morphological abnormality of the inner ear (HP:0011390) | 1.72169321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.08851545 |
| 2 | NTRK3 | 4.42325730 |
| 3 | EPHA4 | 3.93619978 |
| 4 | MAP2K7 | 3.32677785 |
| 5 | MAP3K4 | 3.26237381 |
| 6 | MAP3K12 | 3.02957686 |
| 7 | FRK | 2.90306796 |
| 8 | MARK1 | 2.81144396 |
| 9 | MAP3K9 | 2.77281719 |
| 10 | MINK1 | 2.35518329 |
| 11 | RIPK4 | 2.27021024 |
| 12 | DAPK2 | 2.18326974 |
| 13 | MAP2K4 | 2.12724135 |
| 14 | PLK2 | 2.10644838 |
| 15 | GRK1 | 1.97305747 |
| 16 | CDK19 | 1.96780915 |
| 17 | MAP4K2 | 1.87575875 |
| 18 | DAPK1 | 1.84094332 |
| 19 | BMPR1B | 1.80495595 |
| 20 | DYRK2 | 1.77305455 |
| 21 | PRPF4B | 1.76116890 |
| 22 | TAOK3 | 1.75350952 |
| 23 | TIE1 | 1.74053672 |
| 24 | NTRK2 | 1.73693138 |
| 25 | PNCK | 1.61016402 |
| 26 | SIK3 | 1.59890334 |
| 27 | MAPK13 | 1.58582367 |
| 28 | AKT3 | 1.52831260 |
| 29 | KSR1 | 1.49903503 |
| 30 | CCNB1 | 1.46351893 |
| 31 | TNIK | 1.41770298 |
| 32 | PAK6 | 1.41457566 |
| 33 | GRK5 | 1.37788645 |
| 34 | PRKCG | 1.29243281 |
| 35 | CDK5 | 1.28627372 |
| 36 | BMPR2 | 1.27913570 |
| 37 | SIK2 | 1.26125363 |
| 38 | TLK1 | 1.24377617 |
| 39 | OXSR1 | 1.23856832 |
| 40 | BCKDK | 1.21772095 |
| 41 | MAPKAPK5 | 1.21179963 |
| 42 | CAMK2A | 1.20289023 |
| 43 | TXK | 1.15822501 |
| 44 | KSR2 | 1.15821208 |
| 45 | ZAK | 1.14830735 |
| 46 | WNK4 | 1.14616009 |
| 47 | NME1 | 1.10543086 |
| 48 | ARAF | 1.07525182 |
| 49 | NTRK1 | 1.07414781 |
| 50 | SGK2 | 1.04222966 |
| 51 | CAMK2B | 1.00163696 |
| 52 | OBSCN | 0.98455903 |
| 53 | CAMKK1 | 0.96209457 |
| 54 | SGK494 | 0.94154507 |
| 55 | SGK223 | 0.94154507 |
| 56 | INSRR | 0.93026536 |
| 57 | PTK2B | 0.92903517 |
| 58 | FES | 0.92420923 |
| 59 | CAMKK2 | 0.90621314 |
| 60 | CSNK1G1 | 0.82813540 |
| 61 | PRKCE | 0.78106143 |
| 62 | CSNK1G3 | 0.77763061 |
| 63 | MAP3K13 | 0.77460786 |
| 64 | NUAK1 | 0.75514588 |
| 65 | PHKG1 | 0.75358859 |
| 66 | PHKG2 | 0.75358859 |
| 67 | CDK18 | 0.75094459 |
| 68 | ACVR1B | 0.74707486 |
| 69 | SGK1 | 0.68604709 |
| 70 | CSNK1G2 | 0.68444106 |
| 71 | MAPK15 | 0.68355734 |
| 72 | CDK14 | 0.67565388 |
| 73 | CDK15 | 0.67526807 |
| 74 | FGR | 0.67413323 |
| 75 | BCR | 0.66542694 |
| 76 | DYRK1A | 0.64928481 |
| 77 | STK38 | 0.63783281 |
| 78 | UHMK1 | 0.63775507 |
| 79 | PIK3CA | 0.62916408 |
| 80 | LATS2 | 0.62364950 |
| 81 | MAP3K6 | 0.60983550 |
| 82 | CAMK1 | 0.60506726 |
| 83 | CAMK4 | 0.60137011 |
| 84 | BRAF | 0.60024451 |
| 85 | MAP3K2 | 0.58995962 |
| 86 | SGK3 | 0.57233745 |
| 87 | TSSK6 | 0.57215076 |
| 88 | CDK11A | 0.55763908 |
| 89 | GRK7 | 0.55454775 |
| 90 | CAMK2D | 0.54624800 |
| 91 | CSNK1A1 | 0.54450706 |
| 92 | MUSK | 0.53703228 |
| 93 | RAF1 | 0.53435675 |
| 94 | RPS6KA5 | 0.53130590 |
| 95 | STK11 | 0.52151363 |
| 96 | ADRBK2 | 0.51694700 |
| 97 | CSNK1A1L | 0.51524759 |
| 98 | CAMK2G | 0.48847625 |
| 99 | PRKG1 | 0.48763875 |
| 100 | RET | 0.48433919 |
| 101 | MAPK12 | 0.47567065 |
| 102 | PAK3 | 0.47166331 |
| 103 | CDK3 | 0.46124798 |
| 104 | WNK3 | 0.44721482 |
| 105 | PDK4 | 0.44229714 |
| 106 | PDK3 | 0.44229714 |
| 107 | FER | 0.43778553 |
| 108 | PRKCA | 0.43731040 |
| 109 | PKN1 | 0.43660929 |
| 110 | NEK6 | 0.42831696 |
| 111 | RPS6KA2 | 0.42653740 |
| 112 | TNK2 | 0.41459217 |
| 113 | EPHA3 | 0.41192091 |
| 114 | VRK1 | 0.40999390 |
| 115 | TYRO3 | 0.40710927 |
| 116 | PDK1 | 0.40127738 |
| 117 | MAP2K1 | 0.40074945 |
| 118 | MAP2K2 | 0.39339557 |
| 119 | CSNK1D | 0.38630575 |
| 120 | ADRBK1 | 0.38536124 |
| 121 | PDPK1 | 0.38195407 |
| 122 | EPHB2 | 0.38009717 |
| 123 | MARK2 | 0.37865755 |
| 124 | PRKCQ | 0.37753999 |
| 125 | TRIM28 | 0.37335438 |
| 126 | PRKD3 | 0.37036311 |
| 127 | PINK1 | 0.36807511 |
| 128 | KIT | 0.36255734 |
| 129 | PRKCZ | 0.35803775 |
| 130 | TGFBR1 | 0.35093855 |
| 131 | PRKCH | 0.34948138 |
| 132 | PRKACA | 0.34756093 |
| 133 | FYN | 0.34443143 |
| 134 | RPS6KA3 | 0.33696449 |
| 135 | RPS6KA6 | 0.33577934 |
| 136 | ERBB2 | 0.33367359 |
| 137 | PRKACG | 0.32187845 |
| 138 | ERBB3 | 0.31441583 |
| 139 | STK39 | 0.31023225 |
| 140 | DAPK3 | 0.30830364 |
| 141 | MAPK7 | 0.30668520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.58324457 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.50198525 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.04685455 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.82679644 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.73182429 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.70630060 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.64389434 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.62629365 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.59060926 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.45380813 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.40037257 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.21464505 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.20426033 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.19656906 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.97413964 |
| 16 | Long-term depression_Homo sapiens_hsa04730 | 1.95332232 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.84891034 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.84670614 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.78493995 |
| 20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.74368055 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.74258534 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.67735812 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.60005076 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.59056186 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.55903511 |
| 26 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.53089308 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.44942186 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.44275431 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.44241750 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.42227932 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.38951677 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.36976753 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.25437344 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.24714637 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23962615 |
| 36 | Axon guidance_Homo sapiens_hsa04360 | 1.22438783 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.19127855 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.18321249 |
| 39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.18194456 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.17514164 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.17203680 |
| 42 | Alzheimers disease_Homo sapiens_hsa05010 | 1.16757561 |
| 43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.14957431 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08547467 |
| 45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07572374 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.05276646 |
| 47 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.04265591 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99332549 |
| 49 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.98494755 |
| 50 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.98387139 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98338406 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98261610 |
| 53 | Phototransduction_Homo sapiens_hsa04744 | 0.96669709 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 0.95352458 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 0.92369275 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.90370708 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89135693 |
| 58 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.87794681 |
| 59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.86682741 |
| 60 | Glioma_Homo sapiens_hsa05214 | 0.84391163 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78787048 |
| 62 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74740602 |
| 63 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74324678 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.71668003 |
| 65 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71513436 |
| 66 | Protein export_Homo sapiens_hsa03060 | 0.71229590 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70871564 |
| 68 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.70576163 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68991108 |
| 70 | Huntingtons disease_Homo sapiens_hsa05016 | 0.67465901 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65554232 |
| 72 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65502372 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65110392 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.64391156 |
| 75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63237430 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62090808 |
| 77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61641374 |
| 78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.58529918 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57428222 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57290171 |
| 81 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56926719 |
| 82 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56843879 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.55877737 |
| 84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55776480 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55593872 |
| 86 | Bile secretion_Homo sapiens_hsa04976 | 0.54803084 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.54476002 |
| 88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54106412 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53440730 |
| 90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53428890 |
| 91 | RNA degradation_Homo sapiens_hsa03018 | 0.50334873 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49545837 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49402499 |
| 94 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.47703338 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46019457 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44555281 |
| 97 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44460037 |
| 98 | Basal transcription factors_Homo sapiens_hsa03022 | 0.44246140 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43688501 |
| 100 | Ribosome_Homo sapiens_hsa03010 | 0.43471859 |
| 101 | Alcoholism_Homo sapiens_hsa05034 | 0.42930894 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42571876 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42421303 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.41947636 |
| 105 | ABC transporters_Homo sapiens_hsa02010 | 0.40223185 |
| 106 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39353064 |
| 107 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.39332653 |
| 108 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39090702 |
| 109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38844031 |
| 110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38088197 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37912556 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36669458 |
| 113 | Peroxisome_Homo sapiens_hsa04146 | 0.36440372 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35206297 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34956188 |
| 116 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.34009420 |
| 117 | Histidine metabolism_Homo sapiens_hsa00340 | 0.33765413 |
| 118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33685682 |
| 119 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33400369 |
| 120 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.33350142 |
| 121 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32742593 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32575209 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | 0.32385903 |
| 124 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.29002040 |
| 125 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28365710 |
| 126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26154828 |
| 127 | Melanoma_Homo sapiens_hsa05218 | 0.25811014 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.25454737 |
| 129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24452234 |
| 130 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24140086 |
| 131 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.23597956 |
| 132 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.20955990 |
| 133 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.20914696 |
| 134 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.20577547 |
| 135 | Endometrial cancer_Homo sapiens_hsa05213 | 0.18351547 |
| 136 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.17881543 |

